TBX2 and breast cancer: By modeling aberrant gain-of-function of TBX2 in breast cancer through ectopic expression of TBX2 in non-malignant mammary epithelial cell lines (HC11, MCF10A), we demonstrated that TBX2 alone is sufficient to induce EMT and cell invasion.